magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Online: 2575-7970 ISSN Print: 2575-7989 CODEN: IJCEMH
Frequency: bimonthly Email: ijcemr@hillpublisher.com
Total View: 2462977 Downloads: 553021 Citations: 244 (From Dimensions)
ArticleOpen Access http://dx.doi.org/10.26855/ijcemr.2023.07.020

Mechanism of Occurrence and Development of Fecal Bacteria Transplantation in Functional Constipation

Liang Liang1, Xianglin Liu1, Xi Zhang2,*

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. 

2Xi'an Hospital of TCM, Xi'an, Shaanxi, China.

*Corresponding author: Xi Zhang

Published: August 14,2023

Abstract

Functional constipation is a disease characterized by difficulty in defecation, reduced frequency of defecation, or a feeling of incomplete defecation, and does not meet the diagnostic criteria for irritable bowel syndrome. The incidence rate of the disease is high and the treatment is difficult, which seriously affects the quality of life of patients. Traditional treatment is mainly based on cathartic drugs, but long-term use can cause colon melanosis, intestinal nerve function damage, patient drug tolerance, and other issues, and the treatment effect is not satisfactory. The pathogenesis of functional constipation is complex, and recent studies have shown that it may be related to intestinal flora imbalance, mainly manifested by a decrease in specific anaerobic bacteria and an increase in some harmful bacteria and fungi. Fecal bacteria transplantation is a new type of special organ transplantation, which promotes intestinal peristalsis by reconstructing the structure of intestinal flora. This article reviews the mechanism of occurrence and development of fecal bacteria transplantation in the treatment of functional constipation, providing an effective reference for further clinical application of fecal bacteria transplantation.

Keywords

Functional constipation, Fecal microbiota transplantation, Intestinal flora

References

[1] Crosby EC, Husk KE. Defecatory Dysfunction. Obstet Gynecol Clin North Am. 2021 Sep; 48(3):653-663.

[2] Li JX, Chen J, Ke X. Consensus opinion on the combined diagnosis and treatment of functional constipation in Chinese and Western medicine (2017) [J]. Chinese Journal of Integrative Medicine and Digestion, 2018, 26(01):18-26.

[3] Wald A, Sigurdsson L. Quality of life in children and adults with constipation [J]. Best Pract Res Clin Gastroenterol, 2011, 25 (1):19-27.

[4] Zhao YF, Ma XQ, Wang R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) [J]. Aliment Pharmacol Ther, 2011, 34 (8):1020-1029.

[5] Mekhael M, Kristensen Hø, Larsen H M, et al. Transanal irrigation for neurogenic bowel disease, low anterior resection syndrome, faecal incontinence and chronic constipation:a systematic review [J]. J Clin Med, 2021, 10(4):753.

[6] Yu PL, Li ZJ, Zheng H, et al. Preliminary analysis of the epidemiological characteristics of constipation in the elderly [J]. Chinese Journal of Geriatrics, 2001(02):51-53.

[7] Vanden Berg MM, Benninga MA. Di Lorenzo C. Epidemiology of childhood constipation: A systematic review [J]. Am J Gastroenterol, 2006, 101(10):2401-2419.

[8] Chen Haozhu, Lin Guowei, Wang Jiyao. Practical internal medicine [M]. 14th ed. Beijing: People's Health Publishing House, 2013:1959-1962.

[9] Wang L, Jiang J, Ding WW, et al. Characteristics of changes in colonic mucosal flora in patients with persistent constipation [J]. Parenteral and enteral nutrition, 2014, 21(01):12-15. DOI:10.16151/j.1007-810x.2014.01.014.

[10] Soldi S, Vasileiadis S, Uggeri F, et al. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach [J]. Clin Exp Gastroenterol, 2015, 8:309-325.

[11] Khalif IL, Quigley EM, Konovitch EA, et al. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation [J]. Dig Liver Dis, 2005, 37(11):838-849.

[12] Liu HN, Chen YZ, Wu H, et al. Research progress on intestinal flora and functional constipation [J]. Journal of Fudan (Medical Edition), 2015, 42(04):564-568.

[13] Gopanandan Parthasarathy, Jun Chen, Xianfeng Chen, Nicholas Chia, Helen M. O'Connor, Patricia G. Wolf, H. Rex Gaskins, Adil E. Bharucha. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Me-thane Production in Female Patients With Chronic Constipation [J]. Gastroenterology, 2016, 150(2).

[14] Wang F, Zhang YL, Yao SK, et al. Analysis of symptom characteristics and intestinal microecology in patients with severe functional constipation [J]. Journal of Difficult Diseases, 2014, 13(07):707-709+713.

[15] Wang J, Bai X, Peng C, et al. Fermented milk containing Lactobacillus casei Zhang and Bifidobacterium animalis ssp. lactis V9 alleviated constipation symptoms through regulation of intestinal microbiota, inflammation, and metabolic pathways [J]. J Dairy Sci, 2020, 103(12):11025-11038.

[16] Dimidi E, Christodoulides S, Scott SM, et al. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation [J]. Adv Nutr, 2017, 8(3):484-494.

[17] Zhang F, Luo W, Shi Y, et al. Should we standardize the 1, 700 -year-old fecal microbiota transplantation? [J]. Am J Gastorenterol, 2012, 107 (11):1755.

[18] Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembrannous enterocolitis [L]. Surg, 1958, 44 (5):854-859.

[19] Merrick B, Allen L, Masirah M Zain N, et al. Regulation, risk and safety of Faecal Microbiota Transplant [J]. Infect Prev Pract, 2020, 2(3):100069.

[20] Gulati M, Singh S K, Corrie L, et al. Delivery routes for faecal microbiota transplants: Available, anticipated and aspired [J]. Pharmacol Res, 2020, 159:104954.

[21] Long C, Yu Y, Cui B, et al. A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video [J]. BMC Gastroenterol, 2018, 18(1):37.

[22] Chen QY, Yang B, Tian HL et al. Five-year follow-up analysis of treatment outcomes and complications in 3,932 cases of flora transplantation [J]. Chinese Journal of Gastroenterology, 2020, 40(11):768-777.

[23] Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOO Pulating’ the gut [J]. Microbiome, 2013, 1 (1):3.

[24] Wen Q, Zhang FM. A new method of fecal bacteria transplantation: detergent colony transplantation [J]. Jiangsu Health Care, 2021, No.287(11):55.

[25] Khoruts A, Dicsved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent clostridium diffcile-associated diarrhea [J]. J Clin Gastroenterol, 2010, 44 (5):354-360.

[26] Gong S, Yan Z, Liu Z, et al. Intestinal microbiota mediates the susceptibility to polymicrobial sepsisinduced liver injury by granisetron generation in mice [J]. Hepatology, 2019, 69(4):1751-1767.

[27] Singh S, Heady S, Coss-Adame E, et al. Clinical utility of colonic manometry in slow transit constipation [J]. Neurogastroenterol Motil, 2013, 25(6):487-495.

[28] Li N, Tian HL, Chen QY, et al. Analysis of the efficacy of flora transplantation for the treatment of intestinal diseases in 2010 cases [J]. Chinese Journal of Gastrointestinal Surgery, 2019, 22(09):861-868.

[29] Li N, Tian HL, Ma CL et al. Efficacy analysis of 406 cases of intestinal diseases treated with flora transplantation [J]. Chinese Journal of Gastrointestinal Surgery, 2017, 20(01):40-46.

[30] Matsuoka K, Mizuno S, Hayashi A, et al. Fecal Microbiota Transplantation for Gastrointestinal Diseases [J]. Keio J Med, 2014, 63(4):69-74.

[31] Van Nood E, Vrieze A, Nierwdrop M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile [J]. N Engl J Med, 2013, 368 (5):407-415.

[32] Bakken JS, Borody t, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation [J]. Clin Gastroenterol Hepatol, 2011, 9 (12):1044-1049.

[33] Hmailton MJ, Weingarden AR, Sadowsky MJ, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection [J]. Am J Gastroenterol, 2012, 107 (5):761-767.

[34] LI SS, Zhu A, BENES V, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation [J]. Science, 2016, 352(6285):586-589.

[35] Zhang XL, Tian HL, Ma CL, et al. Observation on the efficacy of staged flora transplantation for intractable constipation [J]. Chinese Journal of Gastrointestinal Surgery, 2017, 20(12):1355-1359.

[36] Establishment and clinical application of a standardized methodology for bacteriophage transplantation by Chinese expert consensus [J]. Chinese Journal of Gastrointestinal Surgery, 2020, 23(Z1):5-13.

How to cite this paper

Mechanism of Occurrence and Development of Fecal Bacteria Transplantation in Functional Constipation

How to cite this paper: Liang Liang, Xianglin Liu, Xi Zhang. (2023) Mechanism of Occurrence and Development of Fecal Bacteria Transplantation in Functional Constipation. International Journal of Clinical and Experimental Medicine Research7(3), 401-406.

DOI: http://dx.doi.org/10.26855/ijcemr.2023.07.020